Description
Basic introduction
This is a catalog blend of a CJC-related GHRH analog and ipamorelin. It brings two named research components into one listing, so composition and the exact CJC form are important parts of the material specification.
The individual components have different experimental backgrounds. Research on a single component is useful for designing a comparison, but it does not establish the behavior, stability or superiority of a combined vial.
Mechanism of action · Research context
GHRH-related component
The CJC component belongs to GHRH analog research. Confirm whether the material includes DAC or another modification before selecting a published analog as a scientific comparator.
Secretagogue component
Ipamorelin is a separate pentapeptide secretagogue. Its original characterization included pituitary and animal experiments, with hormone release measured as a functional response.
Convergent experimental endpoints
Different pathways may converge on hormone release. A measured combined response does not demonstrate synergy unless the experiment includes a suitable design and each component alone.
Extended research considerations
Blend composition
Confirm the amount and identity of each component. Total powder mass cannot reveal their individual proportions or establish that both peptides retain their intended structure.
Compatibility measurements
Mixture stability is its own analytical question. Examine intact-component recovery and assay compatibility instead of assuming that single-component handling data transfer unchanged to a blend.
Comparative study design
Vehicle, each constituent and the blend provide different controls. Keeping those conditions separate makes it possible to interpret a response without attributing every change to a combined mechanism.
Material and packaging
Listed appearance: White Lyophilized Powder.
Available kit specifications: 10 mg × 10 vials. Select an option above to view its current price and availability.
Storage and handling
Source-listed storage condition: Store at -20°C (Protect from light and moisture). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.
Analytical documentation
Reference analytical documents are available with this listing. Check the material identity, batch number and test date against the batch supplied; contact us for current batch documentation.
Scientific references
These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.
- Ipamorelin experimental characterization
- Modified CJC-1295 research context
View report
Parker T. –
I used to buy CJC and Ipamorelin separately, and this pre-blended kit saves so much time. The powder is bright white right out of the vial, and dissolves easily with gentle swirling without harsh shaking. Vial-to-vial strength is extremely uniform.
Fioren Quinton –
The powder stays loose and never hardens into dense chunks at the bottle bottom. I take small dry powder samples with a sterile spatula instead of dissolving the whole vial for quick screening tests, cutting peptide waste nearly in half.
Hesper Rowe –
I run comparison tests on dual peptide synergy, CP10’s fixed equal mix ratio keeps my comparison data accurate. Whether I use full vial liquid for large animal tests or tiny dry samples for micro screening, the peptide balance never shifts between batches.
Jasper Carter –
After 10 consecutive months of monthly bulk restocks, CP10 is my lab’s exclusive dual CJC 1295 (No DAC) + Ipamorelin blend for all synergistic growth hormone and body composition research. Independent ≥99% HPLC purity verification for both compounds, clear stable -20°C dark storage guidelines, fixed balanced 1:1 mass formulation, and ultra-repeatable in-vivo & in-vitro trial results eliminate all data inconsistency issues I faced with separate single-peptide sourcing and generic mixed blends. Every published aging endocrinology study from my lab relies on CP10’s consistent, reliable synergistic biological activity batch after batch.
Ivor O. –
Both peptide molecular formulas, CAS numbers and molecular weights match the official datasheet perfectly. Independent HPLC testing on each component confirms zero filler contaminants or fragmented peptide chains. Dark low-temperature storage prevents oxidation of both peptides simultaneously.